Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ASTCNASDAQ:BNGONASDAQ:PRPONASDAQ:STAI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTCAstrotech$5.78+0.4%$5.92$5.74▼$12.29$9.78M0.2514,884 shs1,618 shsBNGOBionano Genomics$3.75+1.9%$3.81$2.68▼$53.29$12.62M2.36106,585 shs49,623 shsPRPOPrecipio$11.20-1.5%$7.25$3.90▼$11.76$16.93M1.289,624 shs8,586 shsSTAIScantech AI Systems$0.78+1.3%$1.40$0.68▼$5.20$19.95M-0.884.40 million shs289,612 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTCAstrotech0.00%+0.09%0.00%-11.43%-38.24%BNGOBionano Genomics0.00%+2.18%-2.22%-8.09%-93.18%PRPOPrecipio0.00%+13.14%+73.24%+61.62%+97.18%STAIScantech AI Systems0.00%+9.72%-42.93%-57.66%+77,899,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASTCAstrotech1.0674 of 5 stars0.05.00.00.01.90.80.6BNGOBionano Genomics1.2318 of 5 stars3.12.00.00.01.10.00.6PRPOPrecipio1.0518 of 5 stars0.04.00.00.02.52.50.0STAIScantech AI SystemsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTCAstrotech 0.00N/AN/AN/ABNGOBionano Genomics 2.25Hold$7.0086.67% UpsidePRPOPrecipio 0.00N/AN/AN/ASTAIScantech AI Systems 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest STAI, PRPO, BNGO, and ASTC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/9/2025BNGOBionano GenomicsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.004/2/2025BNGOBionano GenomicsScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$1.00 ➝ $4.00(Data available from 6/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTCAstrotech$903K10.83N/AN/A$20.45 per share0.28BNGOBionano Genomics$28.46M0.44N/AN/A$125.85 per share0.03PRPOPrecipio$20.03M0.85N/AN/A$10.16 per share1.10STAIScantech AI Systems$542.17K36.80N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTCAstrotech-$11.67M-$8.42N/A∞N/A-3,198.09%-40.44%-37.41%N/ABNGOBionano Genomics-$232.49M-$138.92N/A∞N/A-407.34%-154.45%-80.78%8/6/2025 (Estimated)PRPOPrecipio-$5.85M-$2.07N/A∞N/A-17.23%-34.01%-25.27%8/11/2025 (Estimated)STAIScantech AI SystemsN/AN/A0.00∞N/AN/AN/AN/AN/ALatest STAI, PRPO, BNGO, and ASTC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025BNGOBionano Genomics-$3.49-$1.15+$2.34-$1.15$6.25 million$6.46 million5/14/2025Q1 2025PRPOPrecipioN/A-$0.59N/A-$0.59N/A$4.93 million5/13/2025Q3 2025ASTCAstrotechN/A-$2.18N/A-$2.18N/AN/A3/27/2025Q4 2024PRPOPrecipio$0.74-$0.23-$0.97-$0.23$8.01 million$5.45 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTCAstrotechN/AN/AN/AN/AN/ABNGOBionano GenomicsN/AN/AN/AN/AN/APRPOPrecipioN/AN/AN/AN/AN/ASTAIScantech AI SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASTCAstrotechN/A10.749.73BNGOBionano Genomics0.071.430.99PRPOPrecipio0.020.730.60STAIScantech AI SystemsN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTCAstrotech24.35%BNGOBionano Genomics11.35%PRPOPrecipio10.45%STAIScantech AI Systems74.04%Insider OwnershipCompanyInsider OwnershipASTCAstrotech14.90%BNGOBionano Genomics1.60%PRPOPrecipio16.90%STAIScantech AI Systems22.77%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASTCAstrotech101.69 million1.45 millionNot OptionableBNGOBionano Genomics3003.36 million1.92 millionOptionablePRPOPrecipio601.51 million1.29 millionNo DataSTAIScantech AI SystemsN/A25.61 million3.45 millionN/ASTAI, PRPO, BNGO, and ASTC HeadlinesRecent News About These CompaniesScanTech AI Secures Allocation for ECAC Certification of Sentinel Fixed-Gantry CT SystemJune 5 at 11:32 PM | nasdaq.comScanTech AI Secures ECAC Allocation to Complete European Certification for Advanced AI-Powered Explosive Detection in AviationJune 4, 2025 | globenewswire.comScanTech AI Announces Shipment of Sixth Sentinel Fixed-Gantry CT System to Enhance Security at Nuclear Energy FacilityJune 4, 2025 | nasdaq.comScanTech delivers sixth Sentinel CT under $3.5M dealJune 3, 2025 | finance.yahoo.comScanTech AI Delivers 6th Sentinel CT System Under $3.5M Nuclear Security ContractJune 2, 2025 | msn.comScanTech AI Delivers 6th Sentinel CT Under $3.5M Deal, Fueling Growth in High-Security Nuclear MarketJune 2, 2025 | globenewswire.comScanTech AI to Attend 10th Annual Smart Airport Conference & ExpositionMay 29, 2025 | globenewswire.comScanTech AI Announces Receipt of Nasdaq Deficiency LettersMay 29, 2025 | globenewswire.comScanTech AI CEO Dolan Falconer Recognized as 2025 Dealmaker of the Year at Smart Business Dealmakers ConferenceMay 21, 2025 | nasdaq.comScanTech AI to Attend 97th Annual AAAE Conference & ExpositionMay 21, 2025 | globenewswire.comScanTech AI Receives the 2025 Dealmaker of the Year Award at Smart Business Dealmakers ConferenceMay 19, 2025 | globenewswire.comScanTech AI Files Its Annual Report on Form 10-K with the U.S. Securities and Exchange ...May 15, 2025 | bakersfield.comScanTech AI Files Its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission (SEC) and Provides Business UpdateMay 15, 2025 | globenewswire.comScanTech AI CEO Dolan Falconer Announced as Featured Speaker at 2025 Smart Business Dealmakers Conference in AtlantaMay 13, 2025 | globenewswire.comScanTech AI Eliminates $30M in Legacy Debt with Equity Restricted Shares, Strengthening Balance Sheet and Protecting Stockholder ValueMay 8, 2025 | globenewswire.comScanTech AI Systems Reaches New Financial AgreementsMay 3, 2025 | investing.comScanTech AI delivers advanced security system to Canadian nuclear siteApril 30, 2025 | investing.comScanTech AI Expands Strategic Role in Critical Infrastructure Security with Additional Sentinel® System Deployment to Canadian Nuclear FacilityApril 29, 2025 | globenewswire.comFormer U.S. Customs Chief Endorses CustomsTrace AI™ as Critical to National and Economic SecurityApril 23, 2025 | globenewswire.comScanTech AI Systems Inc (STAI)April 18, 2025 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesPfizer's 7.5% Dividend: Income Haven or House of Cards?By Jeffrey Neal Johnson | May 23, 2025View Pfizer's 7.5% Dividend: Income Haven or House of Cards?BigBear.ai: Risky AI Stock or Defense Tech Opportunity?By Jeffrey Neal Johnson | May 28, 2025View BigBear.ai: Risky AI Stock or Defense Tech Opportunity?3 Underrated Stocks Quietly Delivering Big GainsBy Thomas Hughes | May 13, 2025View 3 Underrated Stocks Quietly Delivering Big GainsSalesforce’s Stock Price Presents an Opportunity to BuyBy Thomas Hughes | May 29, 2025View Salesforce’s Stock Price Presents an Opportunity to BuyPalo Alto Networks: Buy The Dip, Long-Term Tailwinds AheadBy Thomas Hughes | May 21, 2025View Palo Alto Networks: Buy The Dip, Long-Term Tailwinds AheadSTAI, PRPO, BNGO, and ASTC Company DescriptionsAstrotech NASDAQ:ASTC$5.78 +0.03 (+0.43%) As of 06/6/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, cargo and other secured facilities, and borders. In addition, it develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.Bionano Genomics NASDAQ:BNGO$3.75 +0.07 (+1.90%) Closing price 06/6/2025 04:00 PM EasternExtended Trading$3.70 -0.05 (-1.44%) As of 06/6/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.Precipio NASDAQ:PRPO$11.20 -0.17 (-1.50%) Closing price 06/6/2025 03:59 PM EasternExtended Trading$11.26 +0.07 (+0.58%) As of 06/6/2025 05:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.Scantech AI Systems NASDAQ:STAI$0.78 +0.01 (+1.31%) As of 06/6/2025 04:00 PM EasternScantech AI Systems, Inc. engages in the innovation, emerging technology, and machine learning expertise. ScanTech specializes in developing advanced screening technology that provides the most accurate and fastest detection of prohibited materials. The company was founded on September 5, 2023 and is headquartered in Buford, GA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/02 - 06/06 This Banking Giant Just Got a $90 Price Target Upgrade Broadcom Slides on Solid Earnings, AI Outlook Still Strong The Market’s Silent Warning: What Bonds and Gold Reveal MongoDB Affirms Outlook and Accelerates Stock Price Reversal Are NVIDIA's Ethernet Wins Signs of Hope or Horror for Arista? AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio? Why Visa's Innovation Engine Keeps It a Top Portfolio Pick Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
